These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

45 related items for PubMed ID: 3525362

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The value of C-peptide level measurements in diabetes mellitus.
    Rajasoorya C, Tan YT, Chew LS.
    Ann Acad Med Singap; 1990 Jul; 19(4):463-6. PubMed ID: 2221804
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Monogenic diabetes: a useful dimension for diabetology practice].
    Valéro R, Béliard S, Paquis-Fluckinger V, Vialettes B.
    Ann Endocrinol (Paris); 2005 Jun; 66(3):279-83. PubMed ID: 15988391
    [Abstract] [Full Text] [Related]

  • 28. Oral hypoglycaemic activity of an anhydroformaldehyde aniline-insulin mixture.
    Wales JK, Bradley P, Wolff FW.
    Nature; 1966 Jul 02; 211(5044):88-9. PubMed ID: 5967478
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Oral antidiabetic drug use in the elderly.
    Bressler R, Johnson DG.
    Drugs Aging; 1996 Dec 02; 9(6):418-37. PubMed ID: 8972242
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Beta cell function in long term NIDDM (type 2) patients and its relation to treatment.
    Snehalatha C, Ramachandran A, Mohan V, Timothy H, Viswanathan M.
    Horm Metab Res; 1986 Jun 02; 18(6):391-4. PubMed ID: 3525362
    [Abstract] [Full Text] [Related]

  • 33. Pancreatic beta cell response in insulin treated NIDDM patients limitations of a random C-peptide measurement.
    Snehalatha C, Ramachandran A, Mohan V, Viswanathan M.
    Diabete Metab; 1987 Feb 02; 13(1):27-30. PubMed ID: 3552773
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
    Pontiroli AE, Calderara A, Pacchioni M, Cassisa C, Pozza G.
    Diabete Metab; 1993 Feb 02; 19(1):30-5. PubMed ID: 8504882
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Beta cell function in long term NIDDM (type 2) patients and its relation to treatment.
    Snehalatha C, Ramachandran A, Mohan V, Timothy H, Viswanathan M.
    Horm Metab Res; 1986 Jun 02; 18(6):391-4. PubMed ID: 3525362
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
    van der Wal PS, Draeger KE, van Iperen AM, Martini C, Aarsen M, Heine RJ.
    Diabet Med; 1997 Jul 02; 14(7):556-63. PubMed ID: 9223393
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.